Stephanie Shisler
Obstetrics & Gynecology · Rockwall, TXNPI 1902898356
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,800 of the $18,995 with a category attached, or 72.7%. Astellas Pharma US Inc accounts for 77.3% of it on its own, with 36 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $68.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$15K
- AbbVie$984
- Mayne Pharma Commercial LLC$419
- Sumitomo Pharma America, Inc.$413
- Millicent US Inc$324
- Pfizer$316
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$13,80073%
- Food & beverage$5,05527%
- Education$1391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 28 | $14,678 |
| AbbVie(2 entities) | 71 | $984 |
| Mayne Pharma Commercial LLC | 17 | $419 |
| Sumitomo Pharma America, Inc. | 24 | $413 |
| Millicent US Inc | 17 | $324 |
| Pfizer | 16 | $316 |
| Exeltis, USA Inc. | 10 | $201 |
| Myovant Sciences Inc. | 14 | $187 |
| Therapeuticsmd, Inc. | 11 | $186 |
| Organon | 6 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $131 |
| Evofem Biosciences, Inc. | 5 | $96 |
| Novo Nordisk | 5 | $91 |
| Minerva Surgical, Inc | 3 | $70 |
| Bayer | 4 | $66 |
| Daiichi Sankyo Inc. | 4 | $66 |
| Merck | 4 | $58 |
| Mylan Pharmaceuticals Inc. | 3 | $55 |
| AMAG Pharmaceuticals, Inc. | 4 | $54 |
| Avion Pharmaceuticals | 3 | $47 |
| Duchesnay USA Incorporated | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Agile Therapeutics, Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $39 |
| Lilly USA, LLC | 1 | $26 |
| Meditrina | 1 | $25 |
| Baxter Healthcare | 1 | $22 |
| Amgen | 1 | $22 |
| Mycovia Pharmaceuticals, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Ascend Therapeutics US, LLC | 1 | $19 |
| Axonics, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Lupin Inc. | 1 | $11 |
| Channel Medsystems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$13,874
How this compares
$18,995 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 42 | $1,670 |
| ProgesteroneProgesterone, Micronized | 11 | $569 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Rockwall
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.